Reportedly, NEU1 has been implicated in the pathogenesis of various metabolic disorders, including diabetes mellitus, obesity, and non‐alcoholic fatty liver disease, all of which are associated with dysregulated glycolysis.[19, 20, 21, 22] Indeed, we have observed a notable upregulation of NEU1 mRNA and protein levels in both NRCMs and cardiac tissue under DOX conditions. Here, NEU1 is linked to Other metabolic disease.